Wednesday, March 13, 2019 8:28:29 AM
Looks interesting. Found the needle in the haystack....?
From Seeking Alpha(which means little)
On a 10 times revenue valuation basis only on domestic market, a conservative valuation for Pharmacielo would stand at 2.5B, resulting in a 25$/shares price target for 2020.
Since the company is starting sales in 2019 and still has market confirmations to provide, we would apply a 40% discount to price in such risk.
Therefore, our current price target for the stock is 15$ per share.
Recent PCLO News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - PCLO • PR Newswire (Canada) • 05/08/2024 12:38:00 PM
- Canadian Investment Regulatory Organization Trading Halt - PCLO • PR Newswire (Canada) • 05/08/2024 12:36:00 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM